nice open, page-20

i am harder than a british rail scone when it comes to TIS - i think the buying is coming from overseas and those that get the aussie biotech story - look at the success of ACR / MSB.

ACR took off and I think TIS can mimic this.

TIS has great margins, stock ready to go and a market that is growing "sloths with ulcers" its a great story.

apparently SM is a detail man, smart man and yes communcation or lack thereof but we are on the cusp of something great.